These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 8292731)
21. Sex-related differences in plasminogen activator and plasminogen activator inhibiting activities in young and aged rats. Kojima T; Doi K; Kish M; Horiguchi Y Res Commun Mol Pathol Pharmacol; 1999; 104(1):81-91. PubMed ID: 10604281 [TBL] [Abstract][Full Text] [Related]
22. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate. Wilson MJ; Ludowese C; Sinha AA; Estensen RD Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400 [TBL] [Abstract][Full Text] [Related]
23. Diagnostic efficacy of plasma urokinase-type plasminogen activator and plasminogen activator inhibitor-2 in differentiation of hepatocellular carcinoma from cirrhosis. Song KS; Lee A; Choi JR; Kwon OH Thromb Haemost; 1995 Sep; 74(3):864-7. PubMed ID: 8571313 [TBL] [Abstract][Full Text] [Related]
24. Experimental hypothyroidism inhibits delta-aminolevulinate dehydratase activity in neonatal rat blood and liver. Gravina FS; da Silveira CK; de Assis AM; Rieger DK; Guerini C; Müller AP; Farina M; Rotta LN; Perry ML Exp Biol Med (Maywood); 2007 Sep; 232(8):1021-6. PubMed ID: 17720948 [TBL] [Abstract][Full Text] [Related]
25. Cellular degradation of free and inhibitor-bound tissue-type plasminogen activator--requirement for a co-receptor? Camani C; Gavin O; Kruithof EK Thromb Haemost; 2000 Feb; 83(2):290-6. PubMed ID: 10739388 [TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of urokinase-type plasminogen activator (PA), PA inhibitor type-1, and tissue-type PA antigen levels in node-negative breast cancer: a prospective study on multicenter basis. Kim SJ; Shiba E; Kobayashi T; Yayoi E; Furukawa J; Takatsuka Y; Shin E; Koyama H; Inaji H; Takai S Clin Cancer Res; 1998 Jan; 4(1):177-82. PubMed ID: 9516968 [TBL] [Abstract][Full Text] [Related]
27. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells. Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828 [TBL] [Abstract][Full Text] [Related]
28. Selected parameters of fibrinolysis system in patients with dermatitis herpetiformis. Wankiewicz A; Iwan-Zietek I; Kotschy M; Gwieździński Z Med Sci Monit; 2002 Mar; 8(3):CR189-92. PubMed ID: 11887034 [TBL] [Abstract][Full Text] [Related]
29. Effects of L-thyroxine replacement therapy on carotid intima-media thickness in patients with primary hypothyroidism. Cakal E; Turgut AT; Demirbas B; Ozkaya M; Cakal B; Serter R; Aral Y Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):294-300. PubMed ID: 19085705 [TBL] [Abstract][Full Text] [Related]
30. Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice. Declerck PJ; Verstreken M; Collen D Thromb Haemost; 1995 Nov; 74(5):1305-9. PubMed ID: 8607114 [TBL] [Abstract][Full Text] [Related]
31. Plasminogen activator inhibitor 1 is elevated in the children of men with premature myocardial infarction. Rallidis LS; Megalou AA; Papageorgakis NH; Trikas AG; Chatzidimitriou GI; Tsitouris GK Thromb Haemost; 1996 Sep; 76(3):417-21. PubMed ID: 8883280 [TBL] [Abstract][Full Text] [Related]
32. Plasma cholesteryl ester transfer protein activity is high in infants and is not affected by thyroid hormones. Asami T; Wada M; Uchiyama M Metabolism; 2000 Sep; 49(9):1176-9. PubMed ID: 11016900 [TBL] [Abstract][Full Text] [Related]
33. Biological effects of combined inactivation of plasminogen activator and plasminogen activator inhibitor-1 gene function in mice. Lijnen HR; Moons L; Beelen V; Carmelie P; Collen D Thromb Haemost; 1995 Oct; 74(4):1126-31. PubMed ID: 8560424 [TBL] [Abstract][Full Text] [Related]
34. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells. Fukao H; Hagiya Y; Ueshima S; Okada K; Takaishi T; Izaki S; Matsuo O Thromb Haemost; 1996 Feb; 75(2):352-8. PubMed ID: 8815589 [TBL] [Abstract][Full Text] [Related]
35. Reductions in mRNA of the neuroprotective agent, neuroserpin, after cerebral ischemia/reperfusion in diabetic rats. Liang W; Chuan-Zhen L; Qiang D; Jian Q; Hui-Min R; Bao-Guo X Brain Res; 2004 Jul; 1015(1-2):175-80. PubMed ID: 15223382 [TBL] [Abstract][Full Text] [Related]
36. Modulation of sympathetic activity by tissue plasminogen activator is independent of plasminogen and urokinase. Schaefer U; Vorlova S; Machida T; Melchor JP; Strickland S; Levi R J Pharmacol Exp Ther; 2007 Jul; 322(1):265-73. PubMed ID: 17429057 [TBL] [Abstract][Full Text] [Related]
37. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency. Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147 [TBL] [Abstract][Full Text] [Related]
38. Interrelationships between athyreotic and manganese-deficient states in rats. Oliver JW Am J Vet Res; 1976 May; 37(5):597-600. PubMed ID: 1275346 [TBL] [Abstract][Full Text] [Related]
39. Effects of hyper- and hypothyroidism on the basal levels of angiotensin I and kinetic parameters of renin-angiotensin system in male rats. Jiménez E; Montiel M; Narváez JA; Morell M Rev Esp Fisiol; 1982 Jun; 38(2):149-54. PubMed ID: 7122971 [TBL] [Abstract][Full Text] [Related]
40. Effect of iodobenzene therapy on mitochondrial activity in 2-thiouracil-induced hypothyroidism in weanling rats. Visvanathan A; Narayanan U; Shanmugasundaram KR Res Commun Chem Pathol Pharmacol; 1983 Nov; 42(2):339-42. PubMed ID: 6658195 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]